Dermatology

News

US Vitiligo Study Finds Short Treatment Duration, Variable Care Patterns

09/18/2026

Grace Taylor, MS, MA

A study found that US patients with vitiligo showed short treatment durations and highly variable treatment patterns, while approximately one-third received no treatment following diagnosis.

A study found that US patients...

09/18/2026

First Report Managed Care

News

The Impact of Atopic Comorbidities on Health Care Utilization for Atopic Dermatitis

09/15/2026

Rebecca Amrick

New research suggests an association between atopic comorbidities and health care utilization and costs among young children with atopic dermatitis.

New research suggests an...

09/15/2026

First Report Managed Care

News

Real-World Abrocitinib Use Shows Stable Dosing in US Patients With Atopic Dermatitis

09/08/2026

Grace Taylor, MS, MA

A US real-world study found that most patients with atopic dermatitis initiated abrocitinib at 100 mg and maintained their starting dose for up to 12 months.

A US real-world study found that...

09/08/2026

First Report Managed Care

News

The Treatment Landscape and Economic Burden of Chronic Hand Eczema

08/27/2026

Rebecca Amrick

Researchers evaluated treatment patterns and care costs among patients with chronic hand eczema, outlining varied disease presentation, extensive use of corticosteroids, and care costs that increase with treatment intensity.

Researchers evaluated treatment...

08/27/2026

First Report Managed Care

News

Promoting Equitable Care Among Patients With Atopic Dermatitis

08/21/2026

Rebecca Amrick

In a panel hosted by the Academy of Managed Care Pharmacy (AMCP) Market Insights, experts in dermatology and managed care discussed various health disparities for patients with moderate to severe atopic dermatitis, suggesting strategies and...

In a panel hosted by the Academy...

08/21/2026

First Report Managed Care

News

JAK Inhibitors Demonstrate Improved Efficacy Among Various Skin Conditions

08/18/2026

Rebecca Amrick

A systematic review of clinical trials examining the impact of Janus kinase (JAK) inhibitors on skin conditions found that they demonstrated higher efficacy and comparable safety when compared with a placebo.

A systematic review of clinical...

08/18/2026

First Report Managed Care

News

Emerging Research Supports Nonsteroidal Therapies in Pediatric Dermatology

08/12/2026

Rebecca Amrick

Recent research demonstrates the safety and effectiveness of nonsteroidal topical therapies for a variety of pediatric skin conditions, suggesting a possible shift away from traditional corticosteroid treatments.

Recent research demonstrates the...

08/12/2026

First Report Managed Care

Advanced Squamous Cell Carcinoma of the Anal Canal

Videos

Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting

03/31/2026

Lingbin Meng, MD, PhD

Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.

Lingbin Meng, MD, discusses how...

03/31/2026

Journal of Clinical Pathways

News

Immune Marker Profiles Distinguish cSCC From BCC in Tumor Microenvironment Study

12/04/2025

Grace Taylor, MS, MA

A comprehensive tumor microenvironment analysis uncovers key immune marker patterns that sharply distinguish cutaneous squamous cell carcinoma (cSCC) from basal cell carcinoma (BCC), pointing to new opportunities for clinical risk...

A comprehensive tumor...

12/04/2025

First Report Managed Care

News

First-Line Nivolumab Shows Promising Response Rates in Advanced Basal Cell Carcinoma

11/25/2025

Grace Taylor, MS, MA

A study presented at the 2025 European Society for Medical Oncology Congress shows that first-line nivolumab significantly improves response rates in advanced basal cell carcinoma, offering new hope for patients beyond current second-line...

A study presented at the 2025...

11/25/2025

First Report Managed Care

Dermatology

HMP Global Products

Events